Geller Advisors’s Gilead Sciences GILD Stock Holding History

Geller Advisors’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	$238K	Sell	2,578 -4	-0.2%	-$360	0.02%	230
2024 Q3	$216K	Buy	+2,582	New	+$197K	0.02%	249
2024 Q1	–	Sell	-2,652	Closed	-$215K	–	277
2023 Q4	$215K	Sell	2,652 -1,410	-35%	-$110K	0.02%	250
2023 Q3	$304K	Buy	+4,062	New	+$312K	0.04%	185
2022 Q1	–	Sell	-3,332	Closed	-$242K	–	177
2021 Q4	$242K	Sell	3,332 -2	-0.1%	-$138	0.05%	142
2021 Q3	$233K	Sell	3,334 -85	-2%	-$5.97K	0.05%	130
2021 Q2	$235K	Buy	3,419 +11	+0.3%	+$735	0.05%	116
2021 Q1	$220K	Buy	3,408 +1,150	+51%	+$74.2K	0.05%	114
2020 Q4	$209K	Buy	+2,258	New	+$136K	0.05%	107
2020 Q3	–	Sell	-2,728	Closed	-$210K	–	86
2020 Q2	$210K	Buy	+2,728	New	+$209K	0.06%	76

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geller Advisors's GILD Position: Q4 2024 in Review

Geller Advisors reduced its Gilead Sciences (GILD) stake by 0.15% in Q4 2024, selling an estimated $360 and leaving 2,578 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #230.

Geller Advisors first reported a position in GILD in Q2 2020 and has held it in 10 quarters since. The position peaked at $304K in Q3 2023. 1,887 funds tracked by Wall St. Rank hold GILD as of Q4 2024.

Geller Advisors held 2,578 shares of Gilead Sciences worth $238K as of Q4 2024.
Geller Advisors sold 4 Gilead Sciences shares in Q4 2024, an estimated $360.
Gilead Sciences made up 0.02% of Geller Advisors's portfolio in Q4 2024, its #230 holding.
Geller Advisors first reported a position in Gilead Sciences in Q2 2020 and has held it in 10 quarters since.
Geller Advisors's Gilead Sciences position peaked at $304K in Q3 2023.
1,887 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.